Psychiatry

New research finds posttraumatic growth is an important positive factor in life satisfaction for patients with HIV, even after controlling for the negative consequences of stigma and disclosure regret.

In a clinical trial, the reSET-O app increased retention in an outpatient opioid use disorder treatment program.

Investigator Anita Clayton, MD, shares insights into the new vortioxetine data and its implications for patients with depression and treatment-emergent sexual dysfunction.

About half of all MS patients experience an episode of depression during their lifetimes, but most interventions are drug-related or psychiatric.

Most of the patients in the study were taking concomitant antidepressants and/or antipsychotics, and mood disorders remained stable during treatment with valbenazine.

Healthcare provider employment opportunies have risen 7.1%—an increase from 2017's reported rate of 5%. Where are the jobs in most demand?

With a recent FDA approval as the first ever therapy for TD, as well as the first ongoing phase 4 clinical trial, valbenazine use is under close watch by clinicians and specialists.

Patients with tardive syndromes treated with transcranial magnetic stimulation had greater improvement in AIMS scores compared to the sham group.

Ezogabine was not marked as an antidepressant but seemed to be an effective treatment in a small study.

Research with more diverse patient populations is needed to confirm this new discovery.